At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Peter Schmid (Barts Cancer Institute, London, UK) discusses the key challenges in the manufacture, development and approval of biosimilars for breast cancer treatment.
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now